The Chemours Company (CC)
Company Info
Highlights
$1.51B
$0.18
56.17
1.67
$5.80B
$1.10B
$640.00M
$9.26 - $24.51
$14.75
13.05%
3.91
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
The Chemours Company (CC) returned -38.57% year-to-date (YTD) and -58.33% over the past 12 months.
CC
-38.57%
-17.52%
-52.24%
-58.33%
-35.83%
-1.38%
N/A
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of CC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 12.37% | -19.96% | -9.50% | -8.50% | -17.52% | -38.57% | |||||||
| 2024 | -4.34% | -34.25% | 33.50% | 1.87% | -6.40% | -9.06% | 7.09% | -18.45% | 4.53% | -10.63% | 21.28% | -22.26% | -44.01% |
| 2023 | 18.84% | -5.37% | -12.40% | -2.91% | -8.06% | 39.26% | 0.24% | -7.33% | -17.55% | -14.05% | 14.92% | 14.98% | 6.53% |
| 2022 | -2.53% | -14.87% | 14.06% | 5.05% | 31.16% | -25.69% | 11.15% | -4.56% | -26.92% | 16.15% | 9.29% | -1.38% | -5.96% |
| 2021 | 6.25% | -9.77% | 18.61% | 8.20% | 19.86% | -3.14% | -4.45% | 1.52% | -13.28% | -3.58% | 6.85% | 13.00% | 39.88% |
| 2020 | -23.33% | 8.79% | -40.31% | 32.24% | 14.25% | 17.09% | 20.72% | 12.82% | 1.21% | -3.68% | 22.21% | 1.89% | 45.61% |
| 2019 | 26.68% | 7.07% | -2.29% | -3.09% | -40.83% | 13.80% | -20.54% | -24.12% | 5.43% | 9.84% | -2.48% | 14.57% | -32.54% |
| 2018 | 3.12% | -7.63% | 2.53% | -0.62% | 1.53% | -9.45% | 3.27% | -4.27% | -9.54% | -16.30% | -13.03% | -0.91% | -42.45% |
| 2017 | 19.60% | 27.51% | 14.38% | 4.65% | -0.68% | -5.18% | 25.55% | 3.13% | 3.14% | 11.86% | -9.15% | -2.61% | 127.24% |
| 2016 | -26.49% | 30.21% | 37.13% | 30.29% | -4.20% | -5.40% | 12.86% | 42.20% | 21.30% | 2.69% | 50.67% | -10.64% | 317.12% |
| 2015 | -30.73% | -11.45% | -33.09% | 7.11% | -9.39% | -14.24% | -65.84% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CC is 4, meaning it’s performing worse than 96% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for The Chemours Company (CC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
The Chemours Company provided a 8.27% dividend yield over the last twelve months, with an annual payout of $0.84 per share. The company has been increasing its dividends for 8 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.84 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $1.00 | $0.84 | $0.12 | $0.12 | $0.58 |
Dividend yield | 8.27% | 5.92% | 3.17% | 3.27% | 2.98% | 4.03% | 5.53% | 2.98% | 0.24% | 0.54% | 10.82% |
Monthly Dividends
The table displays the monthly dividend distributions for The Chemours Company. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.25 | $0.00 | $0.00 | $0.09 | $0.34 | |||||||
| 2024 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $1.00 |
| 2023 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $1.00 |
| 2022 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $1.00 |
| 2021 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $1.00 |
| 2020 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $1.00 |
| 2019 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $1.00 |
| 2018 | $0.00 | $0.17 | $0.00 | $0.00 | $0.17 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.84 |
| 2017 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.12 |
| 2016 | $0.00 | $0.00 | $0.03 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.00 | $0.03 | $0.00 | $0.12 |
| 2015 | $0.55 | $0.00 | $0.00 | $0.00 | $0.03 | $0.00 | $0.58 |
Dividend Yield & Payout
Dividend Yield
The Chemours Company has a dividend yield of 8.27%, which means its dividend payment is significantly above the market average.
Payout Ratio
The Chemours Company has a payout ratio of 82.16%, which is above the market average. This might signify the company's strong earnings or financial health. However, it could also hint at a more mature business phase with potentially slower growth.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the The Chemours Company. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the The Chemours Company was 86.15%, occurring on Apr 3, 2020. The portfolio has not yet recovered.
The current The Chemours Company drawdown is 76.15%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -86.15% | Oct 30, 2017 | 611 | Apr 3, 2020 | — | — | — |
| -80.12% | Jul 6, 2015 | 143 | Jan 27, 2016 | 172 | Sep 30, 2016 | 315 |
| -22.68% | May 17, 2017 | 29 | Jun 27, 2017 | 18 | Jul 24, 2017 | 47 |
| -21.29% | Dec 9, 2016 | 16 | Jan 3, 2017 | 22 | Feb 3, 2017 | 38 |
| -10.77% | Aug 8, 2017 | 3 | Aug 10, 2017 | 16 | Sep 1, 2017 | 19 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of The Chemours Company over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of The Chemours Company, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -34.5%.
Valuation
The Valuation section provides an overview of how The Chemours Company is priced in the market compared to other companies in the Specialty Chemicals industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CC, comparing it with other companies in the Specialty Chemicals industry. Currently, CC has a P/E ratio of 56.2. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CC compared to other companies in the Specialty Chemicals industry. CC currently has a PEG ratio of 1.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CC relative to other companies in the Specialty Chemicals industry. Currently, CC has a P/S ratio of 0.3. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CC in comparison with other companies in the Specialty Chemicals industry. Currently, CC has a P/B value of 2.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |